Response to Comment on: Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA

Eye (Lond). 2017 Jul;31(7):1113-1114. doi: 10.1038/eye.2017.15. Epub 2017 Feb 24.

S Nghiem-Buffet^{1

2}, S Baillif³, S Regnier⁴, A Skelly⁵, N Yu⁶, A Sodi⁷

¹ Centre Ophtalmologique d'Imagerie et de Laser, Paris, France.
² Department of Ophthalmology, Hôpital Avicenne, Assistance Publique, Hôpitaux de Paris and Paris 13 University, Bobigny, France.
³ Department of Ophthalmology, Pasteur II University Hospital, Nice, France.
⁴ Novartis Pharma AG, Basel, Switzerland.
⁵ Novartis Ireland Limited, Dublin, Ireland.
⁶ Real-World Evidence Solutions, IMS Health, London, UK.
⁷ Department of Ophthalmology, Careggi University Hospital, Florence, Italy.

No abstract available

Publication types